First, the quality of the RNA-seq datasets used in this study was examined: patient-derived AML cells (151 and 21 samples from TCGA-LAML and GSE49642, respectively) and CD34+ normal HPCs derived from bone marrow of healthy volunteers (23 and eight samples from GSE111085 and GSE114922, respectively). Here, CD34 is linked to acute myeloid leukemia.